Hervé Tilly Selected Research

Hervé Tilly Research Topics

Disease

45	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2002
35	Lymphoma (Lymphomas) 02/2024 - 05/2002
30	Neoplasms (Cancer) 12/2023 - 02/2004
26	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2024 - 07/2008
23	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 06/2005
13	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022 - 12/2003
8	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2007
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 01/2014
6	Infections 07/2022 - 05/2015
6	Disease Progression 01/2021 - 07/2008
6	Neutropenia 01/2018 - 11/2005
5	Residual Neoplasm 11/2023 - 01/2016
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2010
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 09/2010
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017 - 09/2010
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024 - 06/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 04/2018
2	Fatigue 01/2020 - 01/2019
2	Fever (Fevers) 08/2018 - 06/2005
2	Febrile Neutropenia 01/2018 - 05/2015
2	Sarcopenia 07/2014 - 04/2014
2	Hematologic Neoplasms (Hematological Malignancy) 11/2013 - 01/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2013 - 08/2011
1	Inflammation (Inflammations) 07/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022
1	Heart Valve Diseases (Valvular Heart Disease) 12/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022

Drug/Important Bio-Agent (IBA)

56	Rituximab (Mabthera)FDA Link 02/2024 - 01/2002
19	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2002
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2002
17	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2002
17	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2002
10	Lenalidomide (CC 5013)FDA Link 10/2022 - 08/2017
8	obinutuzumabIBA 01/2022 - 05/2012
8	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 10/2012
6	polatuzumab vedotinIBA 01/2023 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2012
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 09/2010
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2013
5	Cell-Free Nucleic AcidsIBA 10/2020 - 07/2015
5	Monoclonal AntibodiesIBA 08/2013 - 01/2002
4	Etoposide (VP 16)FDA LinkGeneric 11/2015 - 09/2010
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 06/2005
3	AnthracyclinesIBA 12/2022 - 01/2012
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2022 - 09/2013
3	Gemcitabine FDA Link 01/2022 - 11/2013
3	Bendamustine Hydrochloride FDA Link 01/2021 - 12/2016
3	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2016
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 04/2015
3	Melphalan (Alkeran)FDA LinkGeneric 11/2015 - 04/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2015 - 03/2005
2	Chlorambucil (Leukeran)FDA Link 02/2024 - 06/2017
2	Enhancer of Zeste Homolog 2 ProteinIBA 11/2022 - 06/2015
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2020
2	tazemetostatIBA 11/2020 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 02/2011
2	AntigensIBA 01/2017 - 01/2002
2	Brentuximab VedotinIBA 01/2017 - 03/2016
2	Histone Deacetylase InhibitorsIBA 01/2016 - 04/2015
2	Exportin 1 ProteinIBA 01/2016 - 01/2016
2	Carmustine (FIVB)FDA Link 11/2015 - 12/2014
2	Vindesine (Vindesin)IBA 12/2014 - 03/2005
2	Yttrium-90IBA 12/2014 - 04/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 04/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013 - 11/2005
2	InterferonsIBA 08/2011 - 07/2008
2	Methotrexate (Mexate)FDA LinkGeneric 02/2011 - 09/2010
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Prealbumin (Transthyretin)IBA 07/2023
1	Sodium-Potassium-Chloride SymportersIBA 01/2023
1	Complementary DNA (cDNA)IBA 12/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	ibrutinibIBA 03/2022
1	SaltsIBA 03/2022
1	PlatinumIBA 03/2022
1	NivolumabIBA 01/2022
1	Arginine (L-Arginine)FDA Link 04/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2021
1	FluorineIBA 04/2021

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
35	Therapeutics 10/2022 - 05/2002
15	Stem Cell Transplantation 03/2022 - 05/2002
4	Transplantation 11/2020 - 05/2007
4	Induction Chemotherapy 11/2020 - 12/2003
3	Ligation 01/2020 - 04/2015
3	Salvage Therapy 01/2016 - 07/2008
3	BEAM regimen 11/2015 - 04/2011
2	Autologous Transplantation 01/2021 - 08/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2017
2	VAP-cyclo protocol 05/2013 - 01/2002
2	Radiotherapy 03/2007 - 03/2005
2	Chemoradiotherapy 03/2007 - 03/2005
1	Vascular Access Devices (Arterial Line) 07/2022
1	Catheters 07/2022